PROTEOMONITOR SUBSCRIBERS: SurroMed Spin-Out to Commercialize Barcode-Based Assays for Proteomics

Apr 08, 2002

This story is available to ProteoMonitor subscribers.

Breaking News

T2 Biosystems Q2 Revenues More Than Double, Beat Estimates
Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates
Natera Q2 Revenues Grow 64 Percent
Guardant Health Q2 Revenues Grow 39 Percent
Fluidigm Q2 Revenues Grow 19 Percent
Illumina Q2 Revenues Jump 78 Percent

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.

PROTEOMONITOR SUBSCRIBERS: SurroMed Spin-Out to Commercialize Barcode-Based Assays for Proteomics

T2 Biosystems Q2 Revenues More Than Double, Beat Estimates

Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates

Natera Q2 Revenues Grow 64 Percent

Guardant Health Q2 Revenues Grow 39 Percent

Fluidigm Q2 Revenues Grow 19 Percent

Illumina Q2 Revenues Jump 78 Percent

Review of Approval Process

Not Quite Right

CRISPR and mRNA Together

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

Pacific Biosciences Q2 Revenues Grow 79 Percent

Menopause Timing Influenced by Hundreds of Genetic Loci, New GWAS Finds

Invitae More Than Doubles Q2 Revenues

TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement

Pacific Biosciences Acquires Sample Preparation Firm Circulomics